Exodus Point Capital Management, LP Longboard Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 80,514 shares of LBPH stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
80,514
Previous 41,169
95.57%
Holding current value
$2.96 Million
Previous $889,000
144.77%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding LBPH
# of Institutions
102Shares Held
34.1MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$121 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$108 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$103 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$92.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$87.2 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $500M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...